PHI with Multiple intracerebral hemorrhages
How does this condition affect your private health insurance?
Intracerebral hemorrhage (ICH) at multiple locations refers to bleeding within the brain parenchyma occurring simultaneously or sequentially in more than one distinct area. This severe condition often results from uncontrolled hypertension, cerebral amyloid angiopathy, coagulopathies, or vascular malformations. Multiple ICHs can lead to widespread brain damage, increased intracranial pressure, and significant neurological deficits such as paralysis, speech impairment, cognitive dysfunction, or coma. Its prognosis is typically poor, with high mortality and morbidity rates due to the extensive damage and complex management required, often necessitating intensive care and prolonged rehabilitation.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months for acute stabilization and initial intensive care.
Duration of Illness (Lifetime)
Often a one-time acute event with severe, chronic neurological sequelae requiring lifelong management and rehabilitation.
Cost of Treatment (Initial)
Very high, typically exceeding $100,000 - $500,000 USD due to intensive care, neurosurgery, and extensive initial rehabilitation.
Cost of Treatment (Lifetime)
Extremely high, potentially millions of dollars over a lifetime, including ongoing therapies, medications, assistive devices, and long-term care.
Mortality Rate
High, ranging from 40% to 60% within 30 days, especially with multiple large hemorrhages.
Risk of Secondary Damages
Extremely high (>80-90%), including severe neurological deficits (e.g., hemiparesis, aphasia, cognitive impairment, seizures), hydrocephalus, and increased risk of re-bleeding.
Probability of Full Recovery
Very low (<5-10%), with most survivors experiencing significant and permanent neurological disabilities.
Underlying Disease Risk
High (60-80%), commonly associated with chronic hypertension, cerebral amyloid angiopathy, coagulopathies, arteriovenous malformations, or prior stroke. Multiple sites may suggest systemic issues or specific vasculopathies.